Search Result "integrin v3"


Therapeutic Value of an Integrin Antagonist in Prostate Cancer

Journal: Current Drug Targets
Volume: 17 Issue: 3 Year: 2016 Page: 321-327
Author(s): Clément-Lacroix Philippe

open access plus

Integrins as Therapeutic Targets for Respiratory Diseases

Journal: Current Molecular Medicine
Volume: 15 Issue: 8 Year: 2015 Page: 714-734
Author(s): C. M. Teoh,S. S.L. Tan,T. Tran

Review Article

The Role of αvβ6 Integrin Binding Molecules in the Diagnosis and Treatment of Cancer

Journal: Current Organic Chemistry
Volume: 24 Issue: 21 Year: 2020 Page: 2393-2411
Author(s): Mauricio Urquiza,Valentina Guevara,Erika Diaz-Sana,Felipe Mora

Integrin (αvβ3) Targeted RGD Peptide Based Probe for Cancer Optical Imaging

Journal: Current Protein & Peptide Science
Volume: 17 Issue: 6 Year: 2016 Page: 570-581
Author(s): Zhiguo Liu,Lun Yu,Xiaobo Wang,Xintong Zhang,Meihui Liu,Wenbin Zeng

Vitronectin Receptor -αVβ3 Integrin- Antagonists: Chemical and Structural Requirements for Activity and Selectivity

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 2 Issue: 6 Year: 2002 Page: 531-542
Author(s): Christophe Henry, Nicolas Moitessier, Yves Chapleur

open access plus

Disintegrins from Snake Venoms and their Applications in Cancer Research and Therapy

Journal: Current Protein & Peptide Science
Volume: 16 Issue: 6 Year: 2015 Page: 532-548
Author(s): Jessica Kele Arruda Macedo,Jay W. Fox,Mariana de Souza Castro

Thyroid Hormones Crosstalk with Growth Factors: Old Facts and New Hypotheses

Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Volume: 15 Issue: 1 Year: 2015 Page: 71-85
Author(s): Elena Candelotti,Paolo De Vito,Ragab G. Ahmed,Paolo Luly,Paul J. Davis,Jens Z. Pedersen,Hung-Yun Lin,Sandra Incerpi

RGD-based Therapy: Principles of Selectivity

Journal: Current Pharmaceutical Design
Volume: 22 Issue: 7 Year: 2016 Page: 925-932
Author(s): Mikhail A. Rubtsov,Marina S. Syrkina,Gjumrakch Aliev

Classical and Non-Classical Thyroid Hormone Intracellular Pathways Involved in T Lymphoma Growth

Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Volume: 15 Issue: 1 Year: 2015 Page: 37-42
Author(s): Maria L.B. Arcos,Helena Sterle,Florencia Cayrol,Maria C.D. Flaque,Eduardo Valli,Maria A. Paulazo,Alicia J. Klecha,Graciela A. Cremaschi

Research Article

Disintegrin Tablysin-15 Suppresses Cancer Hallmarks in Melanoma Cells by Blocking FAK/Akt/ERK and NF-κB Signaling

Journal: Current Cancer Drug Targets
Volume: 20 Issue: 4 Year: 2020 Page: 306-315
Author(s): Zhenhui Deng,Qingye Zeng,Jinwei Chai,Bei Zhang,Wenhong Zheng,Xueqing Xu,Jiguo Wu

Previous   Next

Go To   Results 1 - 1 of 161

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


Ads
© 2024 Bentham Science Publishers | Privacy Policy